Drug–microbiota interaction in colon cancer therapy: Impact of antibiotics

Ali Mohamed, Harry Menon, Marina Chulkina, Nelson S. Yee, Irina V. Pinchuk

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Colon adenocarcinoma is one of the most common malignancies, and it is highly lethal. Chemotherapy plays an important role in the treatment of colon cancer at various stages of the disease. The gut microbiome has emerged as a key player in colon cancer development and progression, and it can also alter the therapeutic agent’s efficacy and toxicities. Antibiotics can directly and/or indirectly affect the balance of the gut microbiome and, therefore, the clinical outcomes. In this article, we provided an overview of the composition of the gut microbiome under homeostasis and the mechanistic links between gut microbiota and colon cancer. The relationship between the use of oral antibiotics and colon cancer, as well as the impact of the gut microbiome on the efficacy and toxicities of chemotherapy in colon cancer, are discussed. Potential interventions to modulate microbiota and improve chemotherapy outcomes are discussed. Further studies are indicated to address these key gaps in the field and provide a scientific basis for the design of novel microbiota-based approaches for prevention/use as adjuvant therapeutics for patients with colon cancer.

Original languageEnglish (US)
Article number259
Pages (from-to)1-13
Number of pages13
Issue number3
StatePublished - 2021

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Drug–microbiota interaction in colon cancer therapy: Impact of antibiotics'. Together they form a unique fingerprint.

Cite this